IM
Israa M Shamkh
Also known as: Israa M Ahmed
Research areas: Medicine · Infectious Diseases · Computational Drug Discovery Methods · SARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies
0000-0002-3260-4162
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (31)
- QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors Save
- Computational analysis of bevacizumab binding with protein receptors for its potential anticancer activity Save
- Inhibition of colorectal cancer targets IL-6, CTLA-4, & B7-2 by Tislelizumab: molecular docking, dynamics, & STRING protein-protein network analysis Save
- AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans Save
- Corrigendum to “Inhibition of colorectal cancer targets IL-6, CTLA-4, & B7-2 by Tislelizumab: Molecular docking, dynamics, & STRING protein-protein network analysis” [Inform Med Unlocked 41 (2023) 101323] (Informatics in Medicine Unlocked (2023) 41, (S23… Save
- Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies Save
- In silico Discovery of STRA 6 Vitamin A Receptor, as a Novel Binding Receptor of COVID-19 Save
- Insilico discovering of STRA6 as a Novel Binding Receptor of Human Immunodeficiency (HIV) Save
- Isoform switching leads to downregulation of cytokine producing genes in estrogen receptor positive breast cancer Save
- STRA6 as a Novel Binding Receptor of Human Immunodeficiency Virus (HIV) May Explain Progressive Loss of CD4 T Cell Population and Thymic Dysfunction in HIV Patients Save
- Multi-Epitope Vaccine Design against Monkeypox Virus via Reverse Vaccinology Method Exploiting Immunoinformatic and Bioinformatic Approaches Save
- Nontoxic and Naturally Occurring Active Compounds as Potential Inhibitors of Biological Targets in Liriomyza trifolii Save
- In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19 Save
- Multi-receptor mechanism and retinoid signaling disorder in the pathogenesis of COVID-19 Save
- In Silico Inhibition of Three Cancer Inducing Receptors, IL-6, CTLA-4, and B7-2 by Dostarlimab may explain the 100% Complete Recovery Rate in MMRd Locally Advanced Rectal Cancer seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial. A… Save
- In Silico binding of human immunodeficiency virus (HIV) with STRA6 could explain the mystery of the immunodeficiency caused by HIV infection. An exciting breakthrough in molecular docking and Virology Save
- Corrigendum to "Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2” [J Mol Docking. 2021;1(2):1-14] Save
- In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins Save
- Discovery of the Retinol STRA6 Receptor as a Novel Binding Receptor for SARS-CoV-2 in COVID-19: In Silico Research. Save
- A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses Save